Correlation Between Dominari Holdings and BioCryst Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Dominari Holdings and BioCryst Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Dominari Holdings and BioCryst Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Dominari Holdings and BioCryst Pharmaceuticals, you can compare the effects of market volatilities on Dominari Holdings and BioCryst Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Dominari Holdings with a short position of BioCryst Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Dominari Holdings and BioCryst Pharmaceuticals.
Diversification Opportunities for Dominari Holdings and BioCryst Pharmaceuticals
-0.75 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Dominari and BioCryst is -0.75. Overlapping area represents the amount of risk that can be diversified away by holding Dominari Holdings and BioCryst Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on BioCryst Pharmaceuticals and Dominari Holdings is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Dominari Holdings are associated (or correlated) with BioCryst Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of BioCryst Pharmaceuticals has no effect on the direction of Dominari Holdings i.e., Dominari Holdings and BioCryst Pharmaceuticals go up and down completely randomly.
Pair Corralation between Dominari Holdings and BioCryst Pharmaceuticals
Given the investment horizon of 90 days Dominari Holdings is expected to generate 1.0 times more return on investment than BioCryst Pharmaceuticals. However, Dominari Holdings is 1.0 times more volatile than BioCryst Pharmaceuticals. It trades about 0.01 of its potential returns per unit of risk. BioCryst Pharmaceuticals is currently generating about -0.05 per unit of risk. If you would invest 294.00 in Dominari Holdings on January 31, 2024 and sell it today you would lose (24.00) from holding Dominari Holdings or give up 8.16% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Dominari Holdings vs. BioCryst Pharmaceuticals
Performance |
Timeline |
Dominari Holdings |
BioCryst Pharmaceuticals |
Dominari Holdings and BioCryst Pharmaceuticals Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Dominari Holdings and BioCryst Pharmaceuticals
The main advantage of trading using opposite Dominari Holdings and BioCryst Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Dominari Holdings position performs unexpectedly, BioCryst Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BioCryst Pharmaceuticals will offset losses from the drop in BioCryst Pharmaceuticals' long position.Dominari Holdings vs. CytomX Therapeutics | Dominari Holdings vs. Instil Bio | Dominari Holdings vs. Spero Therapeutics | Dominari Holdings vs. Assembly Biosciences |
BioCryst Pharmaceuticals vs. TG Therapeutics | BioCryst Pharmaceuticals vs. Axsome Therapeutics | BioCryst Pharmaceuticals vs. Seres Therapeutics | BioCryst Pharmaceuticals vs. Madrigal Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.
Other Complementary Tools
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
Content Syndication Quickly integrate customizable finance content to your own investment portal |